Solid Tumor Cancer
📧 Sign up to get email alerts when something new happens for Solid Tumor Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-12Clinical Trial Update: An Educational Intervention on Provider Knowledge for the Support of Cancer Survivors [NA]
This study reports the completion of a clinical trial evaluating an educational intervention designed to improve providers' knowledge in sup…
-
CLINICAL_TRIALS trial_result · 2025-08-03Clinical Trial Update: Levorphanol as a Second Line Opioid in Reducing Pain in Patients With Cancer [EARLY_Phase 1]
Early-phase trial evaluating levorphanol as a second-line opioid for cancer pain has been terminated; no results are provided in this update…
-
CLINICAL_TRIALS trial_result · 2022-04-18Clinical Trial Update: A Study to Evaluate the Effects of Rifampin on Pharmacokinetics (PK) of Pevonedistat in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 study evaluating the effect of rifampin on the pharmacokinetics of pevonedistat in participants with advanced solid tumors has compl…
-
CLINICAL_TRIALS trial_result · 2022-03-16Clinical Trial Update: Propofol vs Sevo for Paediatric Tumor Surgery [Phase 4]
A Phase 4 trial comparing propofol and sevoflurane for pediatric tumor surgery is ongoing.
-
CLINICAL_TRIALS trial_result · 2022-02-02Clinical Trial Update: Study of TBX-3400 in Subjects With Solid Malignant Tumors Resistant or Refractory to Standard Therapies [Phase 1, Phase 2]
Clinical trial update for TBX-3400 in solid malignant tumors resistant or refractory to standard therapies (Phase 1/Phase 2).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-05-28Clinical Trial Update: Study of CRLX101 (NLG207) in the Treatment of Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1/2 clinical trial update for CRLX101 (NLG207) in advanced solid tumors (cancer), completed.